Shashank Sama
No Rating Available
(Learn About Our Rating System)

Shashank Sama, MBBS

Languages spoken: English

  • Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Medical Examiners

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Oncology
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Medical Examiners

    Education history

    Fellowship Hematology & Medical Oncology - University of Utah School of Medicine, Huntsman Cancer Institute Chief Fellow
    Hematology & Medical Oncology - University of Utah School of Medicine, Huntsman Cancer Institute Fellow
    Residency Internal Medicine - University of Connecticut School of Medicine Resident
    Internal Medicine - University of Connecticut School of Medicine Intern
    Professional Medical Medicine, Surgery - Osmania Medical College M.B.B.S.

    Selected Publications

    Journal Article

    1. Smith JT, Sama S, Florou V, Nevala-Plagemann C, Garrido-Laguna I (2023). Durable response to first-line PARP inhibition in BRCA-mutated metastatic cholangiocarcinoma: case report. J Gastrointest Oncol, 14(6), 2637-2643. (Read full article)
    2. Nevala-Plagemann C, Sama S, Ying J, Shen J, Haaland B, Florou V, Garrido-Laguna I (2022). A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States. J Natl Compr Canc Netw, 21(3), 257-264. (Read full article)
    3. Sama S, Kerrigan K, Sinnott JA, Puri S, Akerley W, Haaland B, Patel S (2023). Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer. Cancer Treat Res Commun, 35, 100686. (Read full article)
    4. Lopetegui Lia N, Luke A, Asad SD, Sama S, Wolansky LJ, Hegde UP (2020). Intracranial bleeding following soccer-related head trauma in a young student with occult factor VII deficiency. Clin Case Rep, 8(11), 2148-2151. (Read full article)
    5. Hennessey A, Buller D, Sama S, Girard E, Clement J, Ristau BT (2019). Case report: Adenosquamous carcinoma of the prostate with greater than 20 month response to multimodal therapy. Urol Case Rep, 29, 101084. (Read full article)
    6. Lima G, Kahn A, Sama S, Savage J (2019). Aseptic Meningitis as an Immune-Related Adverse Event after Pembrolizumab. Case Rep Oncol Med, 2019, 7183747. (Read full article)
    7. Sama S, Hadfield MJ, Lopetegui Lia N, Vredenburgh J (2019). Hyperprogression in PDL1 Expressive, Recurrent Gastroesophageal-junction Adenocarcinoma After Pembrolizumab. Cureus, 11(6), e4862. (Read full article)
    8. Kethireddy N, Sama S (2019). Cerebral Sinus Venous Thrombosis in the Setting of Acute Mastoiditis. Cureus, 11(2), e4023. (Read full article)